Abstract:Background & aims: We aim to describe the liver immune microenvironment by analyzing liver biopsies from patients with chronic HBV infection (CHB). Host immune cell signatures and their corresponding localization were characterized by analyzing the intrahepatic transcriptome in combination with a custom multiplex immunofluorescence panel. Method: Matching FFPE and fresh frozen liver biopsies were collected from immune active patients within the open-label phase IV study GS-US-174-0149. RNA-Seq was conducted on 53 CHB liver biopsies from 46 patients. Twenty-eight of the 53 samples had matched FFPE biopsies and were stained with a 12-plex panel including cell segmentation, immune and viral biomarkers. Corresponding serum samples were screened using the MSD Human V-plex Screen Service to identify peripheral correlates for the immune microenvironment. Results: Using unsupervised clustering of the transcriptome, we reveal two unique liver immune signatures classified as immune high and immune low based on the quantification of the liver infiltrate gene signatures. Multiplex immunofluorescence analysis demonstrated large periportal lymphoid aggregates in immune high samples consisting of CD4 and CD8 T cells, B cells and macrophages. Differentiation of the high and low immune microenvironments was independent of HBeAg status and peripheral viral antigen levels. In addition, longitudinal analysis indicates that treatment and normalization of ALT correlates with a decrease in liver immune infiltrate and inflammation. Finally, we screened a panel of peripheral biomarkers and identified ICAM-1 and CXCL10 as biomarkers that strongly correlate with these unique immune microenvironments. Conclusion: These data provide a description of immune phenotypes in patients with CHB and show that immune responses are downregulated in the liver following nucleotide analogue treatment. This may have important implications for both the safety and efficacy of immune modulator programs aimed at HBV cure. Lay summary: Liver biopsies from patients with chronic hepatitis B were submitted to RNA-Seq and multiplex immunofluorescence and identified two different liver immune microenvironments: immune high and immune low. Immune high patients showed elevated immune pathways, including interferon signaling pathways, and increase presence of immune cells. Longitudinal analysis of biopsies from treatment experienced patients showed that treatment correlates with a marked decrease in inflammation and these findings may have important implications for both safety and efficacy of immune modulator programs for HBV cure.

Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populations

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity

Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients

Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics

Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans

Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver

Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis

Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver

Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV

Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice

Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates

Bioinformatics Analysis on Multiple Gene Expression Omnibus Datasets of the Hepatitis B Virus Infection and Its Response to the Interferon-Alpha Therapy

Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy

Interferon stimulated immune profile changes in a humanized mouse model of HBV infection

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma

Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF